NCT01520532View on ClinicalTrials.gov

Evaluation of the Incidence of Cerebral Lesions Post Pulmonary Vein Ablation Catheter (PVAC)

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
Atrial Fibrillation
Interventions
OTHER

Magnetic Resonance Imaging (MRI)

MRI's will be performed on all subjects at Enrollment and Pre-Discharge (Post Ablation). Subjects with a positive MRI (cerebral lesion) at the Pre-Discharge will undergo an MRI at the 1 month follow-up visit.

Trial Locations (7)

Unknown

AZ Middelheim, Antwerp

Imelda Ziekenhuis, Bonheiden

Herz- und Gefäß-Klinik, Bad Neustadt/Saale

Praxisklinik - Herz- und Gefässe, Dresden

Clinica Pineta Grande, Castel Volturno

AZ Sint Antonius Ziekenhuis, Nieuwegein

L3Y 2P9

Southlake Regional Health Center, Newmarket

All Listed Sponsors
lead

Medtronic Cardiac Rhythm and Heart Failure

INDUSTRY

NCT01520532 - Evaluation of the Incidence of Cerebral Lesions Post Pulmonary Vein Ablation Catheter (PVAC) | Biotech Hunter | Biotech Hunter